Pelthos Therapeutics Inc.
PTHS
$26.90
$0.602.28%
AMEX
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 16.16% | 26.78% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 16.16% | 26.78% | |||
| Cost of Revenue | -9.14% | -16.86% | |||
| Gross Profit | 23.21% | 48.49% | |||
| SG&A Expenses | 14.27% | -5.90% | |||
| Depreciation & Amortization | 17.56% | 29.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.16% | -6.04% | |||
| Operating Income | -9.04% | 21.87% | |||
| Income Before Tax | 64.19% | -71.14% | |||
| Income Tax Expenses | -- | -1,388.60% | |||
| Earnings from Continuing Operations | 52.74% | -33.42% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.74% | -33.42% | |||
| EBIT | -9.04% | 21.87% | |||
| EBITDA | -7.44% | 28.12% | |||
| EPS Basic | 54.99% | -29.48% | |||
| Normalized Basic EPS | 65.54% | -64.44% | |||
| EPS Diluted | 54.99% | -29.48% | |||
| Normalized Diluted EPS | 65.54% | -64.44% | |||
| Average Basic Shares Outstanding | 4.98% | 3.04% | |||
| Average Diluted Shares Outstanding | 4.98% | 3.04% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||